胚胎干细胞关键因子Nanog在胶质瘤中的表达及意义

郭雨霁 邴鲁军 刘尚明 郝爱军

doi:10.3969/j.issn.0529-1356.2013.01.001

解剖学报 ›› 2013, Vol. 44 ›› Issue (1) : 1-5. DOI: 10.3969/j.issn.0529-1356.2013.01.001

神经生物学

胚胎干细胞关键因子Nanog在胶质瘤中的表达及意义

郭雨霁,邴鲁军,刘尚明,郝爱军

作者信息 +

Expression of embryonic stem cell-associated factor Nanog in gliomas and its significance

GUO Yu-ji*,BING Lu-jun,LIU Shang-ming,HAO Ai-jun

Author information +

文章历史 +

摘要

目的探讨胚胎干细胞关键因子Nanog在人胶质瘤中的表达及意义。方法通过免疫荧光双标技术，分析40例胶质瘤组织内胚胎干细胞关键因子Nanog与肿瘤干细胞相关基因Nestin、CD133及胚胎干细胞全能性相关基因Oct4 的共表达情况，并通过RT-PCR、Western blotting技术分析胶质瘤组织内Nanog与脑胶质瘤恶性程度之间的关系。结果 Nanog在胶质瘤组织中的表达随着胶质瘤病理级别增高而升高，而且超过50%的Nanog阳性细胞同时表达Nestin和CD133。95%以上的Nanog阳性细胞都同时表达胚胎干细胞全能性相关基因Oct4。结论胶质瘤组织中Nanog多表达在肿瘤干细胞中，与胶质瘤的恶性程度呈正相关，在胶质瘤的发生、发展过程中起着重要作用，为研究胶质瘤的起源及胶质瘤的诊断和预后判断提供帮助。

Abstract

Objective To explore the expression of embryonic stem cell-associated factor Nanog in human gliomas and its significance. Methods Forty cases of human gliomas were examined. The expression of Nanog was analysed by immunohistochemistry, reverse transcription polymerase chain reaction and Western blotting.Double immunofluorescence staining was used to investigate the coexpression of Nanog and markers of cancer stem cells or embryonic stem cell pluripotency-related gene Oct4. Results We found a positive correlation between the expression levels of Nanog and tumour malignancy. Immunohistochemistry showed that Nanogexpressed in both the nuclei and the cytoplasm of glioma cells. Double immunofluorescence staining revealed that more than 50% of Nanog-positive cells coexpressed the putative CSC markers CD133 and Nestin. More than 95% Nanog positive cells also expressed embryonic stem cell pluripotency-related gene Oct4. Conclusion The result suggests that Nanog is mainly expressed in cancer stem cells in gliomas and positively correlated with the malignancy of gliomas. Nanog may play an important role in the progress of gliomas.

导出引用

郭雨霁邴鲁军刘尚明郝爱军. 胚胎干细胞关键因子Nanog在胶质瘤中的表达及意义[J]. 解剖学报. 2013, 44(1): 1-5 https://doi.org/10.3969/j.issn.0529-1356.2013.01.001

Expression of embryonic stem cell-associated factor Nanog in gliomas and its significance[J]. Acta Anatomica Sinica. 2013, 44(1): 1-5 https://doi.org/10.3969/j.issn.0529-1356.2013.01.001

中图分类号： A

参考文献

［1］ Sell S. Stem cell origin of cancer and differentiation therapy ［J］. Crit Rev Oncol Hematol，2004，51(1):1-28.
［2］Ponti D,Costa A,Zaffaroni N,et al.Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties ［J］. Cancer Res, 2005,65(13):5506-5511.
［3］Sagar J, Chaib B, Sales K, et al. Role of stem cells in cancer therapy and cancer stem cells: a review ［J］. Cancer Cell Int, 2007,7：9.
［4］Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors ［J］. Nat Genet, 2008,40(5):499-507.
［5］Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors ［J］. Cancer Res, 2003,63(18): 5821-5828. 
［6］Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors ［J］. Proc Natl Acad Sci USA, 2003, 100(25): 15178-15183. ［7］Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells ［J］. Cancer Cell, 2007,11(1):69-82.
［8］Beier D, Wischhusen J, Dietmaier W, et al. CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors ［J］. Brain Pathol, 2008,18(3):370-377. 
［9］Beier D, Hau P, Proescholdt M, et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles ［J］. Cancer Res, 2007, 67(9):4010-4015.
［10］Purow BW, Haque RM, Noel MW, et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation ［J］. Cancer Res, 2005, 65(6): 2353-2363. 
［11］Ruizi Altaba A, Sanchez P,Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells ［J］. Nat Rev Cancer, 2002, 2(5): 361-372. 
［12］Dahmen RP, Koch A, Denkhaus D, et al. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas ［J］. Cancer Res, 2001, 61(19): 7039-7043. 
［13］Monk M, Holding C. Human embryonic genes re-expressed in cancer cells ［J］. Oncogene, 2001, 20(56): 8085-8091.
［14］Chang CC, Shieh GS, Wu P, et al. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells ［J］. Cancer Res, 2008, 68(15): 6281-6291. 
［15］Chiou SH, Yu CC, Huang CY, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma ［J］. Clin Cancer Res, 2008, 14(13): 4085-4095. 
［16］Hart AH, Hartley L, Ibrahim M, et al. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human ［J］. Dev Dyn, 2004,230(1):187-198.
［17］Jeter CR, Badeaux M, Choy G, et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development ［J］. Stem Cells, 2009,27(5):993-1005.［18］Hoei-Hansen CE, Sehested A, Juhler M, et al. New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers ［J］. J Pathol, 2006,209(1):25-33.